Publication | Closed Access
Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.
139
Citations
20
References
1996
Year
Our recommended dose of cisplatin in combination schedule is therefore 75 mg/m2, representing the optimal balance between efficacy and toxicity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1